SS
ABEO icon

SBI Securities’s Abeona Therapeutics ABEO Stock Holding History

SBI Securities’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$332 Sell
74
-4
-5% -$20 ﹤0.01% 3034
2025
Q4 		$411 Sell
78
-117
-60% -$589 ﹤0.01% 2945
2025
Q3 		$1.03K Buy
195
+33
+20% +$209 ﹤0.01% 2683
2025
Q2 		$920 Sell
162
-396
-71% -$2.25K ﹤0.01% 2716
2025
Q1 		$2.66K Buy
558
+341
+157% +$1.85K ﹤0.01% 2175
2024
Q4 		$1.21K Buy
+217
New +$1.33K ﹤0.01% 2524

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SBI Securities's ABEO Position: Q1 2026 in Review

SBI Securities reduced its Abeona Therapeutics (ABEO) stake by 5.1% in Q1 2026, selling an estimated $20 and leaving 74 shares worth $332. The position accounts for ﹤0.01% of the portfolio, ranked #3034.

SBI Securities first reported a position in ABEO in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.66K in Q1 2025. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • SBI Securities held 74 shares of Abeona Therapeutics worth $332 as of Q1 2026.
  • SBI Securities sold 4 Abeona Therapeutics shares in Q1 2026, an estimated $20.
  • Abeona Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #3034 holding.
  • SBI Securities first reported a position in Abeona Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Abeona Therapeutics position peaked at $2.66K in Q1 2025.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.